Fund Holdings — Novo Holdings A/S

Total Portfolio Value:
$1.31B
Total Bought:
$93.95M
Total Sold:
$259.43M
Net Transaction:
-$165.48M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Vanguard Index FdsTotal Stock Market1,038,5501,038,5500$300.98M$285.44M21.71%-$15.55M
Brookfield CorporationCL A(BN)2,798,8302,330,830-468,000$160.79M$122.16M9.29%-$38.63M
Edgewise Therapeutics, Inc.(EWTX)5,000,0005,350,000+350,000$133.50M$117.70M8.95%-$15.80M
Asml Holding N VN Y REGISTRY SHS
N Y REGISTRY SHS
165,836165,8360$114.94M$109.89M8.36%-$5.05M
Salesforce, Inc.(CRM)293,901272,801-21,100$98.26M$73.21M5.57%-$25.05M
Mirum Pharmaceuticals, Inc.(MIRM)1,500,0001,500,0000$62.02M$67.58M5.14%+$5.55M
Insmed Incorporated(INSM)724,666724,6660$50.03M$55.28M4.21%+$5.25M
Recursion Pharmaceuticals, Inc.CL A(RXRX)10,114,6339,665,128-449,505$68.37M$51.13M3.89%-$17.25M
Alibaba Group Holding LimitedADS(BABA)452,327372,327-80,000$38.35M$49.23M3.75%+$10.88M
Crinetics Pharmaceuticals In960,2151,275,000+314,785$49.10M$42.76M3.25%-$6.33M
BioMarin Pharmaceutical Inc.(BMRN)490,000490,0000$32.21M$34.64M2.63%+$2.43M
ArriVent BioPharma, Inc.(AVBP)1,520,6271,872,142+351,515$40.51M$34.62M2.63%-$5.89M
Vaxcyte, Inc.(PCVX)750,000915,000+165,000$61.40M$34.55M2.63%-$26.84M
Merus N V750,000789,129+39,129$31.54M$33.21M2.53%+$1.68M
Viridian Therapeutics, Inc.(VRDN)2,250,0002,250,300+300$43.13M$30.33M2.31%-$12.80M
Pharvaris N V
COM
1,725,0001,725,0000$33.07M$27.08M2.06%-$5.99M
Amicus Therapeutics Inc
COM
2,500,0002,750,000+250,000$23.55M$22.44M1.71%-$1.11M
Celldex Therapeutics, Inc.(CLDX)1,000,0001,200,000+200,000$25.27M$21.78M1.66%-$3.49M
Blueprint Medicines Corp175,000228,804+53,804$15.26M$20.25M1.54%+$4.99M
Zenas BioPharma, Inc.(ZBIO)1,600,0002,214,967+614,967$13.10M$17.50M1.33%+$4.39M
CeriBell, Inc.(CBLL)328,809880,000+551,191$8.51M$16.90M1.29%+$8.40M
Verve Therapeutics Inc2,400,0003,000,000+600,000$13.54M$13.71M1.04%+$174.0K
Rocket Pharmaceuticals, Inc.(RCKT)1,100,0001,100,0000$13.83M$7.34M0.56%-$6.49M
4d Molecular Therapeutics In1,500,0001,950,000+450,000$8.36M$6.30M0.48%-$2.06M
Lexeo Therapeutics, Inc.(LXEO)1,122,5811,122,5810$7.39M$3.90M0.30%-$3.49M
LanzaTech Global, Inc.(LNZA)15,814,84515,814,8450$21.67M$3.83M0.29%-$17.84M
Io Biotech Inc3,354,4493,354,4490$3.09M$3.66M0.28%+$570.3K
Kyverna Therapeutics, Inc.(KYTX)1,850,0001,850,0000$6.92M$3.57M0.27%-$3.35M
AbCellera Biologics Inc.(ABCL)1,126,9151,126,9150$3.30M$2.51M0.19%-$788.8K
Marqeta, Inc.CL A(MQ)441,558441,5580$1.67M$1.82M0.14%+$145.7K
Damora Therapeutics, Inc.(DMRA)99,91399,9130$464.6K$309.7K0.02%-$154.9K
Cargo Therapeutics Inc1,663,7240-1,663,724$23.99M$0—-$23.99M
Mersana Therapeutics Inc.4,250,0000-4,250,000$6.08M$0—-$6.08M
Tempus AI, Inc.CL A(TEM)4,074,4190-4,074,419$137.55M$0—-$137.55M
Page 1 of 1
Novo Holdings A/S — 13F Holdings — Q1 2025 | TickerTrail